Kalaris Therapeutics, Inc.
KLRS
$3.08
$0.5220.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.43M | 100.97M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 3.23M | 1.22M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 91.65M | 102.18M | -- | ||
|
|
|||||
| Total Current Assets | 91.65M | 102.18M | -- | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 1.19M | 910.00K | -- | ||
| Total Assets | 92.84M | 103.09M | -- | ||
|
|
|||||
| Total Accounts Payable | 3.68M | 2.37M | -- | ||
| Total Accrued Expenses | 3.83M | 4.54M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | 142.00K | 230.00K | -- | ||
| Total Other Current Liabilities | 142.00K | 230.00K | -- | ||
| Total Current Liabilities | 7.65M | 7.14M | -- | ||
|
|
|||||
| Total Current Liabilities | 7.65M | 7.14M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 32.08M | 32.08M | -- | ||
| Total Liabilities | 39.73M | 39.22M | -- | ||
|
|
|||||
| Common Stock & APIC | 191.22M | 190.63M | -- | ||
| Retained Earnings | -138.11M | -126.76M | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 53.12M | 63.87M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 53.12M | 63.87M | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 53.12M | 63.87M | -- | ||
|
|
|||||